This competing continuation application describes the evolution of this integrated, multidisciplinary, multidepartmental training program over the past 25 years. The goals of the program remain consistent: to produce a new generation of innovative and effective independent cardiovascular investigators, who will become leaders in scientific areas that contribute to the prevention and treatment of cardiovascular disease. The most noticeable changes in """"""""Cardiovascular Mechanisms: Training in Investigation"""""""" reflect the creation of a comprehensive modular curriculum in cardiovascular science. While the cornerstone of the program involves mentored research, all trainees participate in didactic modules in order to develop a broad appreciation for the opportunities and challenges in contemporary cardiovascular research. These didactic sessions are augmented by a monthly journal club that is thematically related to the didactic topic under discussion at the time. All trainees participate in a division-wide research conference held weekly. This conference provides trainees with opportunities to discuss their own work, while simultaneously being exposed to cutting-edge cardiovascular science from other laboratories that address different problems, using different methodologies, but hopefully with a consistent appreciation for developing strong hypotheses, using rigorous scientific methods, and generating high quality, reproducible data. Finally, all trainees are evaluated regularly by their mentors, and their progress is reviewed annually by the larger group of training grant preceptors and an external advisory committee. The major strengths of this program lie in the close interaction of basic and clinical investigators and the collective experience of the preceptors, who over the past 10 years have produced over 100 individuals with full-time academic faculty appointments and/or careers in industry. While their individual success as investigators makes them excellent role models, most important is their commitment to the creation of a culture of discovery that teaches and reinforces the skills and behaviors of the successful scientist in those entrusted to their mentoring.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Institutional National Research Service Award (T32)
Project #
5T32HL007411-30
Application #
7642456
Study Section
Special Emphasis Panel (ZHL1-CSR-G (F1))
Program Officer
Carlson, Drew E
Project Start
1994-09-30
Project End
2011-06-30
Budget Start
2009-07-01
Budget End
2011-06-30
Support Year
30
Fiscal Year
2009
Total Cost
$454,697
Indirect Cost
Name
Vanderbilt University Medical Center
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
004413456
City
Nashville
State
TN
Country
United States
Zip Code
37212
Gupte, Manisha; Tumuluru, Samvruta; Sui, Jennifer Y et al. (2018) Cardiomyocyte-specific deletion of GSK-3? leads to cardiac dysfunction in a diet induced obesity model. Int J Cardiol 259:145-152
Gupte, Manisha; Umbarkar, Prachi; Lal, Hind (2017) Mechanistic Insights of Empagliflozin-Mediated Cardiac Benefits: Nearing the Starting Line : Editorial to: ""Empagliflozin Improves Left Ventricular Diastolic Dysfunction in a Genetic Model of Type 2 Diabetes"" by N. Hammoudi et al. Cardiovasc Drugs Ther 31:229-232
Bylund, Jeffery B; Trinh, Linh T; Awgulewitsch, Cassandra P et al. (2017) Coordinated Proliferation and Differentiation of Human-Induced Pluripotent Stem Cell-Derived Cardiac Progenitor Cells Depend on Bone Morphogenetic Protein Signaling Regulation by GREMLIN 2. Stem Cells Dev 26:678-693
Guo, Yuanjun; Gupte, Manisha; Umbarkar, Prachi et al. (2017) Entanglement of GSK-3?, ?-catenin and TGF-?1 signaling network to regulate myocardial fibrosis. J Mol Cell Cardiol 110:109-120
Jefferson, Angela L; Liu, Dandan; Gupta, Deepak K et al. (2017) Lower cardiac index levels relate to lower cerebral blood flow in older adults. Neurology 89:2327-2334
Vander Roest, Mark J; Merryman, W David (2017) A developmental approach to induced pluripotent stem cells-based tissue engineered heart valves. Future Cardiol 13:1-4
Bradham, William S; Bell, Susan P; Adkisson, Douglas W et al. (2017) Myocardial T1 Measurement Predicts Beneficial LV Remodeling After Long-Term Heart Failure Therapy. J Card Fail 23:262-265
Zhu, Lin; Giunzioni, Ilaria; Tavori, Hagai et al. (2016) Loss of Macrophage Low-Density Lipoprotein Receptor-Related Protein 1 Confers Resistance to the Antiatherogenic Effects of Tumor Necrosis Factor-? Inhibition. Arterioscler Thromb Vasc Biol 36:1483-95
Sanders, Lehanna N; Schoenhard, John A; Saleh, Mohamed A et al. (2016) BMP Antagonist Gremlin 2 Limits Inflammation After Myocardial Infarction. Circ Res 119:434-49
Wu, Jing; Montaniel, Kim Ramil C; Saleh, Mohamed A et al. (2016) Origin of Matrix-Producing Cells That Contribute to Aortic Fibrosis in Hypertension. Hypertension 67:461-8

Showing the most recent 10 out of 120 publications